Catalysts for $RIGL
11 tracked
Nov 3, 2026
earnings
RIGEL PHARMACEUTICALS INC earnings
RIGEL PHARMACEUTICALS INC
→
Dec 22, 2025
approval
GAVRETO (PRALSETINIB) — FDA approval
RIGEL PHARMACEUTICALS INC
→
Mar 22, 2024
approval
GAVRETO (PRALSETINIB) — FDA approval
RIGEL PHARMACEUTICALS INC
→
Aug 9, 2023
approval
GAVRETO (PRALSETINIB) — FDA approval
RIGEL PHARMACEUTICALS INC
→
Jul 20, 2023
approval
GAVRETO (PRALSETINIB) — FDA approval
RIGEL PHARMACEUTICALS INC
→
Jun 30, 2023
approval
GAVRETO (PRALSETINIB) — FDA approval
RIGEL PHARMACEUTICALS INC
→
Sep 28, 2022
approval
GAVRETO (PRALSETINIB) — FDA approval
RIGEL PHARMACEUTICALS INC
→
Feb 2, 2022
approval
GAVRETO (PRALSETINIB) — FDA approval
RIGEL PHARMACEUTICALS INC
→
Nov 10, 2021
approval
GAVRETO (PRALSETINIB) — FDA approval
RIGEL PHARMACEUTICALS INC
→
Sep 4, 2020
approval
GAVRETO (PRALSETINIB) — FDA approval
RIGEL PHARMACEUTICALS INC
→
Sep 4, 2020
approval
GAVRETO (PRALSETINIB) — FDA approval
RIGEL PHARMACEUTICALS INC
→